Hereditary Hemorrhagic Telangiectasia and Term Life Insurance in 2026

Yes, HHT affects your life insurance rates. This is not a deal breaker, but carriers do view this genetic condition as a higher risk because of potential complications like nosebleeds requiring transfusions, pulmonary arteriovenous malformations, brain AVMs, and gastrointestinal bleeding. The good news is that coverage is readily available, and you have real control over what rate class you receive based on how you present your application.

Why HHT Affects Your Life Insurance Rates

Underwriters see hereditary hemorrhagic telangiectasia as a condition with variable but potentially serious outcomes. When we help clients with HHT apply for coverage, carriers focus on whether you have developed organ complications. Someone with only minor nosebleeds faces a completely different evaluation than someone who has experienced a stroke from a brain AVM or needed embolization procedures for lung AVMs.

The severity spectrum matters enormously. Mild HHT with manageable nosebleeds might land you at Table 2 or Table 4. Moderate disease with a history of pulmonary AVMs that have been successfully treated could place you anywhere from Table 4 to Table 8 depending on the carrier and your current stability. Severe cases involving multiple organs, recurrent serious bleeding, or neurological events may face graded ratings or even postponement until stability is demonstrated.

What Underwriters Actually Evaluate for HHT

Carriers use specific criteria when reviewing your application. These are the exact factors that determine whether you pay 25 percent more or double the standard rate.

Primary factors include your specific HHT manifestations and which organs are affected. Underwriters want detailed information about nosebleed frequency and severity, particularly whether you have required cauterization, laser therapy, or blood transfusions. They evaluate any history of pulmonary AVMs, brain AVMs, or spinal AVMs along with treatment details and outcomes. Your gastrointestinal bleeding history matters significantly, as does liver involvement or hepatic AVMs. Current functional status and how HHT impacts your daily activities also factor into the decision.

Secondary considerations include your screening compliance and results from imaging studies showing any new or growing AVMs. Underwriters review your history of procedures like embolization or surgery, your current medications including any iron supplementation for anemia, and other health conditions that might complicate HHT. Family history of severe complications can also influence the decision, along with whether you experience chronic anemia requiring ongoing management.

Hereditary Hemorrhagic Telangiectasia Rates: Understanding Table Ratings

Table ratings sound complicated but work simply. Standard rates are what someone in perfect health pays. Each table adds 25 percent. Table 1 means 25 percent above standard. Table 2 is 50 percent higher. Table 4 doubles the cost.

Put this in real numbers. A healthy 40 year old might pay $45 per month for $500,000 in 20 year term coverage. That same person with mild HHT at Table 2 would pay roughly $67 per month. At Table 4, the cost jumps to around $90 per month. At Table 8, you are looking at approximately $135 per month.

This is where many people make a critical mistake. They assume HHT means automatic decline or unaffordable rates. A $50 monthly difference between what you expected and what you actually pay is significant, but it is also $50 that protects your family with half a million dollars if something happens to you. Compared to your mortgage payment or car insurance, this remains affordable protection.

Whole Life Insurance and Universal Life Insurance Options with HHT

Term life insurance gets most of the attention, but whole life and universal life policies deserve consideration when you have HHT.

Whole life insurance builds cash value while providing permanent coverage. When we work with HHT clients on whole life policies, the underwriting process mirrors term life evaluation, but the permanent nature of coverage can make the higher premium worthwhile if you need lifelong protection. The cash value component grows tax deferred and can serve as an emergency fund, which some clients value given the unpredictable nature of HHT complications.

Universal life insurance offers flexible premiums and death benefits with a cash value component. This flexibility appeals to clients whose HHT symptoms may fluctuate or who anticipate changes in their financial situation. The policy can adjust as your needs evolve, though the same underwriting standards apply at issue.

Both permanent policy types will typically come with table ratings similar to term insurance based on your HHT severity. The key difference is cost. Permanent insurance costs significantly more than term because it covers you for life and includes the savings component. A 40 year old paying $90 monthly for term coverage at Table 4 might pay $400 to $600 monthly for a comparable whole life policy.

The Independent Agency Advantage for HHT Cases

This matters more with HHT than almost any other condition. Different carriers can rate the exact same health profile two to four tables apart. One carrier might offer you Table 6 while another offers Table 3 for identical medical records. That difference translates to hundreds of dollars annually.

We founded Insurance By Heroes as former first responders and military spouses specifically to bring this elite level of service to everyone. Every member of our team comes from a public service background. We apply that same thoroughness and duty driven approach to protecting all families, regardless of whether you have ever served. Our independent status means we can compare dozens of carriers to find which one treats your specific HHT presentation most favorably.

Some carriers have more experience with rare genetic conditions and use more nuanced underwriting. Others apply broad stroke ratings that penalize you unfairly. Shopping this properly is not optional if you want to avoid overpaying by thousands of dollars over your policy term.

Positioning Your Application for the Best Possible Outcome

You have real control over your rating through preparation and documentation.

What helps your application tremendously includes mild manifestations limited to manageable nosebleeds without transfusion needs. Successful treatment of any AVMs with good outcomes and no residual complications strengthens your case. Regular screening showing stable disease with no new AVMs demonstrates responsible management. Good functional status where HHT does not limit your work or daily activities signals lower risk. Managing any anemia effectively without requiring frequent transfusions also helps. Long intervals since any serious bleeding episodes or procedures show stability. Compliance with specialist recommendations and preventive screening proves you take the condition seriously.

What hurts your application includes recent serious complications like stroke, significant hemorrhage, or hospitalizations. Multiple organ systems involved rather than isolated telangiectasias raises concern. Frequent need for interventions such as repeat embolizations or cauterizations signals poorly controlled disease. Chronic severe anemia requiring regular transfusions indicates significant impact. Poor response to treatments or progressive disease on imaging creates underwriting hesitation. Any neurological complications from brain AVMs represent major red flags. Refusing recommended screening or treatment suggests higher future risk.

Documentation That Strengthens Your Case

Gather these records before applying to streamline the process and support the best possible rating.

Recent imaging reports are critical. Underwriters want actual MRI, CT, or ultrasound reports showing current AVM status, not just your description. Pulmonary function tests if you have lung involvement provide objective data. Your screening history and results for brain, lung, and liver AVMs demonstrate responsible monitoring. Treatment records for any procedures like embolization with clear outcome documentation show successful management. Current medication lists and reasons for each help explain your regimen. Hematology records if you manage anemia give the complete picture. Notes from your HHT specialist or genetic counselor add expert perspective. Any genetic testing confirming your specific mutation provides diagnostic clarity.

Common Mistakes That Cost HHT Applicants Money

Saying you have HHT without specifying which manifestations is like saying you have arthritis without clarifying if it is mild finger joint involvement or severe rheumatoid disease. Be specific about exactly which symptoms and organs are affected.

Not knowing your last screening dates and results creates doubt. If you cannot tell the underwriter when you last had brain MRI or chest CT and what those showed, they assume the worst.

Downplaying nosebleed severity backfires when medical records tell a different story. If you needed cauterization or laser treatment multiple times, that is moderate to severe disease, not minor nuisance bleeds.

Forgetting to mention that a previously treated AVM was successfully resolved leaves that complication hanging as an active concern. Make clear what is history versus what is current.

Applying right after a new diagnosis or recent complication almost guarantees a worse rating. Waiting six to 12 months to demonstrate stability can drop you two or three table ratings, saving substantial money.

FAQ

Can I get approved for life insurance with hereditary hemorrhagic telangiectasia?

Yes, most people with HHT can get approved for term life insurance. Your approval depends on your specific symptoms and complications rather than the diagnosis alone. Mild cases often receive table rated offers while more complex cases may face higher ratings or temporary postponement until stability is established.

How much more does life insurance cost with HHT?

Expect to pay 50 to 100 percent more than standard rates for mild to moderate HHT, which typically means Table 2 to Table 4 classifications. A policy that costs $50 monthly at standard rates would run $75 to $100 monthly at these ratings. More severe cases with significant complications may see costs double or triple standard rates.

Should I wait to apply until my HHT is better controlled?

Waiting makes sense only if you recently experienced complications or just started new treatment. A six to 12 month stability period after a significant event can improve your rating substantially. However, waiting years means you age into higher rate brackets and risk developing new complications that worsen your classification. Apply once you have established a stable treatment pattern.

Do I need to disclose HHT if I only get minor nosebleeds?

Absolutely yes. Failing to disclose a diagnosed genetic condition constitutes material misrepresentation and can void your policy when your family needs it most. Even minor manifestations require disclosure, but they typically result in much more favorable ratings than severe complications. Honest disclosure protects your family from claim denials.

Your family deserves the protection you are working to provide. HHT creates some obstacles, but none that prevent you from securing solid coverage at rates that fit your budget. The key is presenting your situation accurately with strong documentation and working with an independent agency that shops your case to carriers who underwrite HHT favorably. Get quotes from multiple sources and see exactly what your coverage will cost rather than assuming you cannot afford protection.